A new study shows that Wegovy remains effective for losing weight and maintaining weight loss for at least four years, doubling the previous estimate. The findings add to growing evidence supporting GLP-1 drugs for weight loss, heart health, and diabetes management.

Related Keywords

Denmark , Danish , Han Chen , Mir Ali , Structural Heart Program , European Congress On Obesity , European Congress , Cheng Han Chen , Medical Director , Memorialcare Heart , Vascular Institute , Saddleback Medical Center , Laguna Hills , Memorialcare Surgical Weight Loss Center , Orange Coast Medical Center ,